Drug Safety Matters
En podkast av Uppsala Monitoring Centre
52 Episoder
-
#35 Veterinary pharmacovigilance part 2 – James Mount
Publisert: 28.1.2025 -
#34 Veterinary pharmacovigilance, Part I – James Mount
Publisert: 17.12.2024 -
#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias
Publisert: 29.11.2024 -
#32 Pharmacovigilance in older adults – Giovanni Furlan
Publisert: 25.10.2024 -
#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori
Publisert: 30.9.2024 -
Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects
Publisert: 26.8.2024 -
Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance
Publisert: 27.6.2024 -
#30 Preventing and reporting medication errors – Rabat CC & UMC
Publisert: 15.5.2024 -
#29 When medicines change our behaviour – Michele Fusaroli
Publisert: 23.4.2024 -
#28 Catching black swans – François Montastruc
Publisert: 29.2.2024 -
#27 When drugs damage the liver – Rita Baião
Publisert: 1.2.2024 -
#26 What's trending in pharmacovigilance? – Angela Caro
Publisert: 20.12.2023 -
#25 A week in the name of medicines safety – part 2
Publisert: 13.11.2023 -
#24 A week in the name of medicines safety – part 1
Publisert: 2.11.2023 -
Uppsala Reports Long Reads – The colour of signals
Publisert: 29.9.2023 -
Uppsala Reports Long Reads – Empowering patients as partners
Publisert: 5.9.2023 -
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Publisert: 27.6.2023 -
#22 Reforming pharmacovigilance education – Michael Reumerman
Publisert: 8.5.2023 -
#21 Unlocking the power of real-world data – Patrick Ryan
Publisert: 30.3.2023 -
#20 The evidence for signals – Daniele Sartori
Publisert: 23.2.2023
Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.
